Drug Screening Market to Witness Huge Growth in 2025 | Key Player Analysis: Abbott, Omega Laboratories Ltd., Roche Monitoring Services, LLC, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Premier BiotechMarket a technical process performed for analyzing specimens such as hair, urine, oral fluids, breath, and .other samples. Drug screening aids in detection of drug or a chemical compound in the body. This process is applied in hospitals, drug testing centers, pain management centers as well as law enforcement agencies. Drug screening tests are also performed by companies and organizations on employees and athletes to check for drug abuse
The "Drug Screening Market Analysis to 2025" is a specialized and in-depth study of the drug screening industry with a focus on the global marketa trend. The report aims to provide an overview of drug screening market with detailed market segmentation by product type, sample, end user, and geography. The drug screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Get Sample Copy of this Report at: bit.ly/2SqAOmP
The consumption of alcohol and drugs has been increased during the previous years, which has been a matter of concern for various employers. Various government bodies have been providing funds for drug screening tests. These factors have fuelled the market of drug screening in the past years and the trend is expected to continue in the coming years as well. Development and adoption of new methods as well as devices for drug screening is expected to provide significant growth opportunities for the market in the future years.
Leading Drug Screening Market Players: Some of the key players influencing the market are Abbott, Omega Laboratories Ltd., Roche Monitoring Services, LLC, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Premier Biotech, Inc., OraSure Technologies, Inc., Psychemedics, Corporation and Laboratory Corporation of America Holdings among others
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the drug screening market based on product type, sample, and end user. It also provides market size and forecast till 2025 for overall drug screening market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Based on the product type, the market is categorized as analytical instruments, rapid testing devices, and consumables. The market is segmented on the basis of sample as, breath, hair, oral fluid, urine, and other samples. Based on end user, the market is classified as drug testing laboratories, drug treatment centers, criminal justice systems & law enforcement agencies, pain management centers, hospitals, individuals, and other end users.
Inquire about this Report at: bit.ly/2PXpGfj
The market for drug screening is anticipated to witness growth in North America during the forecast period, due to the rise in alcohol consumption and drug abuse in the region. Also, stringent laws and rules towards drug abuse are expected to propel the market in North America. Development of better drug and alcohol screening devices is considered to drive the market growth at a steady rate in regions such as Europe and Asia Pacific during the forecast period.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key drug screening manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past three years.
Ask For Discount at: bit.ly/2Obq20n
Besides this, the report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South America after evaluating political, economic, social and technological factors effecting the market in these regions.
The objectives of this report are as follows:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Drug Screening Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Drug Screening Market , thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Get Free 20% Customization on Purchase of this Report @ bit.ly/2D9alpq
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Screening Market to Witness Huge Growth in 2025 | Key Player Analysis: Abbott, Omega Laboratories Ltd., Roche Monitoring Services, LLC, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Premier Biotech here
News-ID: 1333956 • Views: 244
More Releases from The Insight Partners
Field Force Automation (FAA) Market 2019-2027 Study includes Top Key Players as …
Field Force Automation (FAA) is a process that includes real time updation of field information from the field sales team to the management team. The field force automation software tracks and provides real-time update on each and every activity of every sales person, which includes location, status, updates with respect to clients among others. This system is considered to offer its users with enhanced productivity and saves the loss of
Data Analytics Outsourcing Market trend Shows A Rapid Growth by 2027- Accenture, …
The global data analytics outsourcing market valued at US$ 2.49 Bn in 2018 and is expected to grow at a CAGR of 25.8% during the forecast period 2019 – 2027, to account to US$ 19.36 Bn by 2027. The businesses worldwide have realized the importance of analytics for staying ahead in the competitively intensifying environment. The management professional in the companies is increasingly adopting quantified data analytics, predictive analytics, and
Crowdsourced Testing Market by Testing Type, Platform, and Region – Forecast t …
Crowdsourced testing is a method of delegating testing tasks to community of expert testers present across geographies. These experts conduct testing and bring in demographic, knowledge and device diversity to discover defects that are hard to find during routine testing in a simulated environment. Crowdsourced testing is executed mainly to improve the quality of software production from the end-user's perspective. The main advantages of this method are; diversity in terms
Casino Management System Market by Testing Type, Platform, Organization Size, Ve …
The casino management system provides software as well as hardware solutions for different purposes such as player tracking, behavior analysis, security, cash and accounting and others in a casino. Developing countries are increasingly witnessing the emergence of casinos to attract tourists from international borders. The scenario provides a positive outlook in terms of growth and revenue for the major market players involved in the casino management system market during the
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning